QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.
Clinical trial NCT03387085 · TERMINATED
Trial details
- NCT number
- NCT03387085
- Sponsor
- ImmunityBio, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-19
- Primary completion
- 2020-09-11
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.